Stallergenes Greer announces change of auditor

London (United Kingdom) – 20 June 2017 - Stallergenes Greer, a biopharmaceutical company specialising in treatments for respiratory allergies, announces that following the completion of a formal audit tender process, conducted in accordance with the relevant requirements and led by the Company's Audit Committee, the Board has approved the appointment of EY LLP as the Company's auditor for the financial year commencing 1 January 2017. This appointment was approved by shareholders at the Company’s Annual General Meeting held on 8 June 2017.
The Board of Stallergenes Greer extends its appreciation and thanks to PwC LLP for its past contributions.